Canada Life
IBB icon

Canada Life’s iShares Biotechnology ETF IBB Stock Holding History

Canada Life’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2M Sell
95,165
-1,908
-2% -$326K 0.03% 423
2025
Q4 		$16.4M Buy
97,073
+1,249
+1% +$203K 0.03% 420
2025
Q3 		$13.6M Sell
95,824
-5,112
-5% -$698K 0.02% 512
2025
Q2 		$12.8M Sell
100,936
-1,717
-2% -$211K 0.02% 503
2025
Q1 		$13.2M Sell
102,653
-5,440
-5% -$738K 0.02% 502
2024
Q4 		$14.3M Sell
108,093
-1,175
-1% -$165K 0.02% 481
2024
Q3 		$15.9M Sell
109,268
-260
-0.2% -$37.6K 0.03% 465
2024
Q2 		$15.1M Sell
109,528
-3,405
-3% -$455K 0.03% 461
2024
Q1 		$15.5M Sell
112,933
-1,707
-1% -$233K 0.03% 459
2023
Q4 		$15.5M Sell
114,640
-8,928
-7% -$1.09M 0.03% 443
2023
Q3 		$15.1M Sell
123,568
-1,864
-1% -$237K 0.04% 433
2023
Q2 		$16M Sell
125,432
-2,287
-2% -$297K 0.04% 423
2023
Q1 		$16.5M Sell
127,719
-3,132
-2% -$410K 0.04% 420
2022
Q4 		$17.3M Sell
130,851
-5,185
-4% -$670K 0.05% 397
2022
Q3 		$15.9M Buy
136,036
+633
+0.5% +$78.6K 0.05% 394
2022
Q2 		$15.9M Sell
135,403
-1,276
-0.9% -$151K 0.04% 418
2022
Q1 		$19M Sell
136,679
-4,500
-3% -$586K 0.04% 427
2021
Q4 		$21.5M Sell
141,179
-2,770
-2% -$429K 0.04% 401
2021
Q3 		$23.4M Sell
143,949
-198
-0.1% -$33.3K 0.05% 367
2021
Q2 		$23.6M Sell
144,147
-1,114
-0.8% -$172K 0.05% 361
2021
Q1 		$21.7M Sell
145,261
-5,417
-4% -$860K 0.05% 366
2020
Q4 		$22.8M Sell
150,678
-6,764
-4% -$967K 0.04% 395
2020
Q3 		$21.3M Sell
157,442
-2,803
-2% -$380K 0.05% 371
2020
Q2 		$21.8M Sell
160,245
-5,362
-3% -$684K 0.05% 341
2020
Q1 		$18M Sell
165,607
-9,215
-5% -$1.06M 0.05% 333
2019
Q4 		$20.9M Sell
174,822
-1,228
-0.7% -$137K 0.05% 374
2019
Q3 		$17.5M Sell
176,050
-8,755
-5% -$916K 0.04% 399
2019
Q2 		$20.1M Sell
184,805
-2,863
-2% -$305K 0.05% 381
2019
Q1 		$20.9M Buy
187,668
+140
+0.1% +$15.4K 0.06% 317
2018
Q4 		$17.4M Sell
187,528
-3,780
-2% -$401K 0.05% 335
2018
Q3 		$23.4M Sell
191,308
-6,119
-3% -$721K 0.06% 318
2018
Q2 		$21.7M Sell
197,427
-18
-0% -$1.93K 0.05% 332
2018
Q1 		$21.1M Sell
197,445
-3,858
-2% -$428K 0.05% 334
2017
Q4 		$21.4M Sell
201,303
-10,314
-5% -$1.1M 0.05% 344
2017
Q3 		$23.3M Sell
211,617
-3,972
-2% -$425K 0.06% 313
2017
Q2 		$22.2M Sell
215,589
-357
-0.2% -$35.2K 0.06% 314
2017
Q1 		$21.1M Sell
215,946
-8,532
-4% -$817K 0.06% 322
2016
Q4 		$20M Sell
224,478
-5,994
-3% -$546K 0.06% 320
2016
Q3 		$22.2M Sell
230,472
-6,318
-3% -$601K 0.06% 296
2016
Q2 		$20.3M Sell
236,790
-4,218
-2% -$378K 0.06% 311
2016
Q1 		$20.9M Sell
241,008
-10,167
-4% -$909K 0.08% 255
2015
Q4 		$28.3M Sell
251,175
-7,572
-3% -$822K 0.11% 207
2015
Q3 		$26.2M Sell
258,747
-8,115
-3% -$973K 0.1% 212
2015
Q2 		$32.8M Sell
266,862
-18,771
-7% -$2.25M 0.11% 210
2015
Q1 		$32.6M Sell
285,633
-9,780
-3% -$1.08M 0.11% 207
2014
Q4 		$29.8M Buy
295,413
+7,566
+3% +$735K 0.1% 229
2014
Q3 		$26.4M Sell
287,847
-23,397
-8% -$2.05M 0.09% 245
2014
Q2 		$26.6M Sell
311,244
-1,299
-0.4% -$102K 0.09% 243
2014
Q1 		$24.5M Buy
312,543
+618
+0.2% +$51.5K 0.09% 247
2013
Q4 		$23.8M Buy
+311,925
New +$22.1M 0.08% 245

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Life's IBB Position: Q1 2026 in Review

Canada Life reduced its iShares Biotechnology ETF (IBB) stake by 2% in Q1 2026, selling an estimated $326K and leaving 95,165 shares worth $16.2M. The position accounts for 0.03% of the portfolio, ranked #423.

Canada Life first reported a position in IBB in Q4 2013 and has held it in 50 quarters since. The position peaked at $32.8M in Q2 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Canada Life held 95,165 shares of iShares Biotechnology ETF worth $16.2M as of Q1 2026.
  • Canada Life sold 1,908 iShares Biotechnology ETF shares in Q1 2026, an estimated $326K.
  • iShares Biotechnology ETF made up 0.03% of Canada Life's portfolio in Q1 2026, its #423 holding.
  • Canada Life first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 50 quarters since.
  • Canada Life's iShares Biotechnology ETF position peaked at $32.8M in Q2 2015.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.